Screener
BioMarin Pharmaceuticals BMRN Ireland — Total long-lived assets
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by BioMarin Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The source filing: BioMarin Pharmaceuticals’s 10-K, filed February 26, 2026.
- Filed
- Feb 26, 2026, 12:30 PM EST
- Fiscal year
- FY2025
- Accession
- 0001048477-26-000004
FAQ
- What is BioMarin Pharmaceuticals's ireland — total long-lived assets?
- BioMarin Pharmaceuticals (BMRN) reported ireland — total long-lived assets of $331.29M in Q4 2025.
- How has BioMarin Pharmaceuticals's ireland — total long-lived assets changed year-over-year?
- BioMarin Pharmaceuticals's ireland — total long-lived assets increased by 7.5% year-over-year, from $308.12M to $331.29M.
- What does ireland — total long-lived assets mean?
- This metric represents the total book value of non-current, tangible, and intangible assets physically located or legally domiciled within the Ireland geographic segment. These assets typically include manufacturing facilities, specialized laboratory equipment, and capitalized intellectual property associated with regional production hubs. Monitoring this figure helps investors assess the company's capital intensity and infrastructure investment within its international tax and operational footprint.
Ask your AI about BioMarin Pharmaceuticals's ireland — total long-lived assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude